Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TDP2 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement TDP2 dans WB et FACS. Il présente une réactivité envers Humain.
N° du produit ABIN2704362

Aperçu rapide pour TDP2 anticorps (ABIN2704362)

Antigène

Voir toutes TDP2 Anticorps
TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))

Reactivité

  • 49
  • 31
  • 9
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 48
  • 16
Souris

Clonalité

  • 50
  • 14
Monoclonal

Conjugué

  • 28
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp TDP2 est non-conjugé

Application

  • 48
  • 27
  • 26
  • 22
  • 20
  • 13
  • 13
  • 11
  • 8
  • 6
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

Classe de qualité

GMP Grade

Clone

42c
  • Fonction

    Anti-EAPII Unconjugated Antibody

    Attributs du produit

    EAPII (also called TTRAP, TDP2) originally was identified as an interacting partner of oncogene ETS1, a founding member of ets transcription factor, and the cytoplasmic domain of CD40, a member of the tumor necrosis factor (TNF) receptor family. EAPII significantly represses ETS1 transcriptional activity and the synergistic transactivation by ETS1 and AP-1 or by ETS1 and NFκB. EAPII/TTRAP also inhibits the transcriptional activation of NFB induced by CD40 or phorbol 12-myristate 13-acetate (PMA). Recently this protein was also proven to be the first 5'- tyrosyl-DNA phosphodiesterase. EAPII has been demonstrated to have promiscuous protein associations, broad responsiveness to various extracellular signals, and pleiotropic functions in the development of human diseases including cancer and neurodegenerative disease. Emerging data suggest that EAPII is a multi-functional protein: it repairs enzyme (topoisomerase)-mediated DNA damage by removing phosphotyrosine from DNA adducts, involves in multiple signal transduction pathways such as TNF-TNFR, TGFβ and MAPK, and responsive to immune defense including inflammatory response, viral infection and DNA toxins (chemo or radiation therapy). EAPII predominantly localizes to the nucleus, but based on pathological conditions it also localizes in both cytoplasm and nucleus.

    Purification

    Purified

    Pureté

    >95 %

    Immunogène

    Recombinant full length protein

    Isotype

    IgG2b, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C
  • Antigène

    TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))

    Autre désignation

    EAPII

    NCBI Accession

    NM_016614

    UniProt

    O95551
Vous êtes ici:
Chat with us!